SARS-CoV-2 genomic sequencing and metadata reporting
Award Notice Posted
- Solicitation number
- 75D30121C10659
- Agency
-
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- to Mako Medical Laboratories LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D30121C10659 Federal contract award
- NAICS code
- 541380 Testing Laboratories and Services
- Place of performance
- Raleigh NC 27616, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention awarded a fixed price, sole source contract to MAKO Medical Laboratories LLC on May 4, 2021. Under contract number 75D30121C10659, MAKO will provide urgent COVID-19 genomic sequencing and metadata reporting services for $23.4 million. Specifically, MAKO will conduct large-scale viral genomic surveillance of 5,000 SARS-CoV-2 samples per week from 43 states for at least 26 weeks, with options to extend, to inform national and state public health responses to the virus through robust sequencing data.
Notice text
Fixed Price, Sole Source Award for urgent COVID-19 testing and reporting services. Large scale viral genomic survey of COVID-19 samples to provide important baseline information for national and state level surveillance in difining important changes in transmission, identifying unusual or emerging variants, thus improving public health responses and decision-making with better laboratory data. In this project, the Contractor will conduct genomic surveillance using a random set of samples from across the 43 states.
Awarded contract 75D30121C10659 to MAKO MEDICAL LABORATORIES LLC for 23400000.00 on 2021-05-04.
Files
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity